For research and educational purposes only. Not medical advice.
Vardenafil Reference
Educational, not medical advice reference for Vardenafil: Sexual Health; regulatory status, evidence posture, source review, and schedule notes.…
Plain English
- What it is
- Vardenafil is a prescription pill for erectile dysfunction (trouble getting or keeping an erection). It is in the same family as Viagra (sildenafil) and Cialis (tadalafil), a group called PDE5 inhibitors. Its brand names are Levitra and Staxyn, and Staxyn is a version that melts on the tongue.
- What people use it for
- Its FDA-approved job is treating ED in men. It relaxes blood vessels so more blood can flow into the penis when a man is aroused, which means it only works with sexual stimulation. Some people choose it as an alternative when another ED pill gives them too many side effects.
- What the science shows
- Large human studies show it works about as well as sildenafil and tadalafil for ED, with similar side effects like headache, flushing, and a stuffy nose. Doctors often say the best pill is simply the one that suits each person best, so patients may try more than one.
- The catch
- It can be very dangerous, even deadly, if mixed with nitrate heart medicines (like nitroglycerin) or with the drug riociguat, because blood pressure can crash. People with certain heart-rhythm problems (long QT) or on some heart-rhythm drugs should avoid it. It is prescription-only, and any use other than treating ED is off-label.
Reference summary
FDA-approved oral PDE5 inhibitor for erectile dysfunction, backed by large randomized human trials and a full FDA label. It raises cGMP through the nitric-oxide pathway to relax penile smooth muscle with sexual stimulation. Peer-reviewed reviews place its efficacy broadly on par with sildenafil and tadalafil and describe it as a well-tolerated option, which is the basis for the tolerability-alternative framing (not a labeled superiority claim). It carries a distinctive QT caution in addition to the class contraindications.
Regulatory and posture
- Categories
- Sexual Health
- Aliases
- Levitra, Staxyn, Vivanza, vardenafil hydrochloride, BAY 38-9456
- Evidence posture
- human - Labeled use (ED) is backed by human trials; the tolerability-alternative framing reflects comparative reviews, not a labeled superiority claim.
- Regulatory status
- FDA-approved prescription medicine. Approved in 2003 for erectile dysfunction. Two oral forms exist: film-coated tablets (Levitra, now widely generic) and an orally disintegrating tablet (Staxyn) that dissolves on the tongue. The two forms are not interchangeable because the disintegrating tablet produces higher systemic exposure. Not a controlled substance. Any use outside labeled ED treatment is off-label.
- Content review status
- label verified
Selected public sources
- Vardenafil hydrochloride tablet Full Prescribing Information (indication, dosing, contraindications, QT and CYP3A4 warnings)
- Vardenafil orally disintegrating tablet (Staxyn) label: non-interchangeability, alpha-blocker and CYP3A4 restrictions
- PDE5 inhibitors: pharmacology 20 years after sildenafil discovery (mechanism, selectivity)
- Patient preference and satisfaction across sildenafil, vardenafil, tadalafil (individualized selection)